Miscarriage myths persist despite prevalence of medical i...(finding. A majority of people agree...),Health
Navigation Links
Miscarriage myths persist despite prevalence of medical information
Date:12/6/2007
finding.
A majority of people agree that stress can contribute to a bad outcome, and for more long-term behavioral disorders, it's not all that farfetched. But I was studying what people believe rather than what actually causes poor outcomes, he said.
'/>"/>
| Contact: Jonathan Schaffir Schaffir.1@osu.edu 614-293-9899 Ohio State University Source:Eurekalert |
Related medicine news :
1. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
2. New Expert Report Dispels Common Myths About Aspartame
3. Common Foot Myths Trip Us Up
4. Flu Myths Abound in Flu Season
5. Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. Comment Regarding Congregation for the Doctrine of Faith Clarification Concerning Nutrition and Hydration for Patients in a Persistent Vegetative State
8. Chronic infection persists by targeting stromal cell network in lymphoid organs
9. Statin Benefits Persist After Treatment Stops
10. Pursuing parenthood: Discourses of persistence
11. Meniscal damage and the development of persistent knee pain
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:Pitt study suggests craving hinders comprehension without you realizing it 2
[0] Winner Medical Reports Fourth Quarter and Fiscal 2009 Results[0] Pitt study suggests craving hinders comprehension without your realizing it[0] Lilly Announces the First 300-unit Vial of Insulin[0] Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management[0] Pitt study suggests craving hinders comprehension without you realizing it
Other Medicine News:Health News:NutriSystem, Inc. Joins Forces with WomenHeart to Fight Heart Disease 2Health News:NutriSystem, Inc. Joins Forces with WomenHeart to Fight Heart Disease 3Health News:Researchers Zero In on GI Cancers 2Health News:Researchers Zero In on GI Cancers 3Health News:Researchers Zero In on GI Cancers 4Health News:2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate America 2Health News:2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate America 3Health News:2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate America 4Health News:2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate America 5Health News:2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate America 6Health News:FitHeads(R) Helps You Keep Your New Year's Resolution by Getting Your Body and Mind Fit 2Health News:FitHeads(R) Helps You Keep Your New Year's Resolution by Getting Your Body and Mind Fit 3Health News:American Red Cross and HOPE worldwide Honor Dr. Martin Luther King, Jr.'s Legacy 2Health News:American Red Cross and HOPE worldwide Honor Dr. Martin Luther King, Jr.'s Legacy 3
NutriSystem, Inc. Joins Forces with WomenHeart to Fight Heart DiseaseResearchers Zero In on GI Cancers2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate AmericaFitHeads(R) Helps You Keep Your New Year's Resolution by Getting Your Body and Mind FitAmerican Red Cross and HOPE worldwide Honor Dr. Martin Luther King, Jr.'s LegacyHaemonetics to Present at J.P. Morgan Healthcare Conference
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Beemster Cheese Goes Pink In Support of Susan G Komen for the Cure 28R 29 57969 1Beemster Cheese Goes Pink In Support of Susan G Komen for the Cure 28R 29 57969 2Abbott Again Honored for Offering One of the Top 10 Leading Workplaces 57965 1Abbott Again Honored for Offering One of the Top 10 Leading Workplaces 57965 2Abbott Again Honored for Offering One of the Top 10 Leading Workplaces 57965 3Abbott Again Honored for Offering One of the Top 10 Leading Workplaces 57965 4Industry Leaders IRSG and MMI Join Forces to Become Capsa Solutions 28TM 29 57961 1Industry Leaders IRSG and MMI Join Forces to Become Capsa Solutions 28TM 29 57961 2
[0] Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting[0] Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease[0] Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
Other Medicine Technology:Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 2Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 4Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 5Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |